Maggio, 2025 - Happy Life Tv - Page 11

Home2025Maggio (Page 11)

Clinical Trials Demonstrate Monitoring PD-L1 Upregulation Using LifeTracDx Blood Test Could Support New Treatment Path for Metastatic Triple Negative Breast Cancer

MONMOUTH JUNCTION, N.J., May 30, 2025 /PRNewswire/ -- Creatv Bio, a Division of Creatv MicroTech, Inc. ("Creatv") in collaboration with

URGN Investors Have the Opportunity to Lead the UroGen Pharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In UroGen To

URGN Investors Have the Opportunity to Lead the UroGen Pharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In UroGen To

Aker Solutions to supply steel substructure for BalWin2 in Germany

Aker Solutions to supply steel substructure for BalWin2 in Germany

Weekly renewables M&A round-up (May 26 – 30)

Weekly renewables M&A round-up (May 26 – 30)

Vestas unveils 127 MW of wind turbine orders in Italy

Vestas unveils 127 MW of wind turbine orders in Italy

BrightHy becomes agent for Sungrow Hydrogen in Iberia

Translate »